Optimizing COVID-19 Treatment Strategies in Elderly Vulnerable Populations in Canada RFP

Well-being, Health and Biomedical Discovery


Academic Unit: inquire with unit

Memorial Deadline: Wednesday 16th, August 2023

External Deadline: Wednesday 23rd, August 2023


Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the practice gaps as outlined in the specific RFP.

For all independent quality improvement grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct or monitoring of the quality improvement program.

Date RFP Issued: June 29, 2023

Geographic Scope: Canada

Clinical Area: COVID-19

Link to full RFP: Optimizing COVID-19 Treatment Strategies in Elderly Vulnerable Populations in Canada

Application Due Date: August 23, 2023

Specific Area of Interest: Potential applicants are encouraged to utilize QI programs to optimize COVID-19 treatment implementation strategies in elderly vulnerable populations in areas including, but not limited to:

  • Clinical practice to improve COVID-19 treatment outcomes such as drug-drug interactions management, early diagnosis, early treatment initiation strategies, and disease awareness

Novel clinical pathways to optimize treatment uptake to prevent the risk of complications from COVID-19
Refer to complete details in the full RFP document. If you have questions regarding this RFP, please direct them in writing to Derek Warnick, Grant Officer (derek.warnick@pfizer.com).

Funding Sources

Pfizer Inc

This opportunity was posted by: RGCS

Last modified: July 19, 2023